OREX

Orexo is a Swedish specialty pharmaceutical company dedicated to improving the lives of patients suffering from opioid use disorder and other mental health conditions. The company's primary commercial product is Zubsolv, a sublingual tablet for the treatment of opioid dependence. Orexo leverages its proprietary drug delivery platform, amorphOX, to develop improved formulations of existing drugs, particularly for emergency and acute care. In addition to its pharmaceutical portfolio, the company has expanded into digital therapeutics, offering evidence-based digital interventions for depression and substance use disorders. Orexo operates with a strong commercial presence in the United States and continues to advance a pipeline focused on rescue medications and mental health.